Literature DB >> 19153151

Live imaging of Toll-like receptor 2 response in cerebral ischaemia reveals a role of olfactory bulb microglia as modulators of inflammation.

M Lalancette-Hébert1, D Phaneuf, G Soucy, Y C Weng, J Kriz.   

Abstract

Activation of microglial cells in response to ischaemic injury, inflammatory and/or immune stimuli is associated with the marked induction of Toll-like receptor 2 (TLR2). At present, little is known about the spatial and temporal sequence of events, micro-regional specificities and the potential long term role of the TLR2 response to brain injuries. To investigate microglial activation/TLR2 response in real time, we generated a transgenic mouse model bearing the dual reporter system luciferase/green fluorescent protein under transcriptional control of a murine TLR2 promoter. In this model, transcriptional activation of TLR2 was visualized in the brains of live animals using biophotonic/bioluminescence molecular imaging and a high resolution/sensitivity charged coupled device camera. It was found that TLR2 induction/microglial activation has a marked chronic component after ischaemic injury and may last several months after the initial attack. The pro-inflammatory response was not restricted to the site of ischaemic injury but was also evident in the olfactory bulb. A significant TLR2 response was first seen in the olfactory bulb 6 h after stroke and several hours before the increase in photon emission over the site of infarction. This sequence of events was further confirmed by immunohistochemistry. A similar early TLR2 response from olfactory bulb microglia was observed in the brain's immune response to pathogens. We therefore propose that, owing to their unique situation, receiving and translating numerous inputs from the brain as well as from the environment, olfactory bulb microglia may serve as sensors and/or modulators of brain inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153151     DOI: 10.1093/brain/awn345

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  51 in total

Review 1.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

Review 2.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 3.  The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.

Authors:  Douglas M Durrant; Soumitra Ghosh; Robyn S Klein
Journal:  ACS Chem Neurosci       Date:  2016-04-08       Impact factor: 4.418

Review 4.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

Review 5.  Microglia and Neonatal Brain Injury.

Authors:  Carina Mallard; Marie-Eve Tremblay; Zinaida S Vexler
Journal:  Neuroscience       Date:  2018-01-17       Impact factor: 3.590

Review 6.  Microglia dynamics and function in the CNS.

Authors:  Christopher N Parkhurst; Wen-Biao Gan
Journal:  Curr Opin Neurobiol       Date:  2010-08-10       Impact factor: 6.627

7.  Blocking TLR2 in vivo protects against accumulation of inflammatory cells and neuronal injury in experimental stroke.

Authors:  Gina Ziegler; Dorette Freyer; Denise Harhausen; Uldus Khojasteh; Wilfried Nietfeld; George Trendelenburg
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-15       Impact factor: 6.200

8.  A transgenic mouse model for the in vivo bioluminescence imaging of the expression of the lysophosphatidic acid receptor 3: relevance for inflammation and uterine physiology research.

Authors:  Chenqi Zhao; Anne Sardella; Lynn Davis; Patrice E Poubelle; Sylvain G Bourgoin; Maria J Fernandes
Journal:  Transgenic Res       Date:  2015-05-16       Impact factor: 2.788

9.  Microglia and ischemic stroke: a double-edged sword.

Authors:  Anita R Patel; Rodney Ritzel; Louise D McCullough; Fudong Liu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-05-27

10.  Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke.

Authors:  Karsten Ruscher; Enida Kuric; Yawei Liu; Helene L Walter; Shohreh Issazadeh-Navikas; Elisabet Englund; Tadeusz Wieloch
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.